Gastroenterology
Volume 134, Issue 1 , Pages 120-130 , January 2008

Krüppel-Like Factor 5 Mediates Cellular Transformation During Oncogenic KRAS-Induced Intestinal Tumorigenesis

  • Mandayam O. Nandan

      Affiliations

    • Division of Digestive Diseases, Department of Medicine, Emory University, Atlanta, Georgia
    • ,
  • Beth B. McConnell

      Affiliations

    • Division of Digestive Diseases, Department of Medicine, Emory University, Atlanta, Georgia
    • ,
  • Amr M. Ghaleb

      Affiliations

    • Division of Digestive Diseases, Department of Medicine, Emory University, Atlanta, Georgia
    • ,
  • Agnieszka B. Bialkowska

      Affiliations

    • Division of Digestive Diseases, Department of Medicine, Emory University, Atlanta, Georgia
    • ,
  • Hongmiao Sheng

      Affiliations

    • Department of Surgery, Indiana University, Indianapolis, Indiana
    • ,
  • Jinyi Shao

      Affiliations

    • Department of Surgery, Indiana University, Indianapolis, Indiana
    • ,
  • Brian A. Babbin

      Affiliations

    • Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia
    • ,
  • Sylvie Robine

      Affiliations

    • Morphogenesis and Intracellular Signalling, Institut Curie-Centre National de la Recherche Scientifique, Paris, France
    • ,
  • Vincent W. Yang

      Affiliations

    • Division of Digestive Diseases, Department of Medicine, Emory University, Atlanta, Georgia
    • Winship Cancer Institute, Emory University, Atlanta, Georgia
    • Corresponding Author InformationAddress requests for reprints to: Vincent W. Yang, MD, PhD, 201 Whitehead Biomedical Research Building, Emory University School of Medicine, 615 Michael Street, Atlanta, Georgia 30322. fax: (404) 727-5767.

Received 19 July 2007 ,Accepted 10 September 2007.

References 

  1. Barbacid M. ras genes. Annu Rev Biochem. 1987;56:779–827
  2. Bos JL. ras oncogenes in human cancer: a review. Cancer Res. 1989;49:4682–4689
  3. Bos JL. The ras gene family and human carcinogenesis. Mutat Res. 1988;195:255–271
  4. Feig LA, Schaffhausen B. Signal transduction (The hunt for Ras targets). Nature. 1994;370:508–509
  5. Kodaki T, Woscholski R, Hallberg B, et al. The activation of phosphatidylinositol 3-kinase by Ras. Curr Biol. 1994;4:798–806
  6. Malumbres M, Barbacid M. RAS oncogenes: the first 30 years. Nat Rev Cancer. 2003;3:459–465
  7. Marais R, Marshall CJ. Control of the ERK MAP kinase cascade by Ras and Raf. Cancer Surv. 1996;27:101–125
  8. Marshall CJ. Ras effectors. Curr Opin Cell Biol. 1996;8:197–204
  9. Marshall MS. Ras target proteins in eukaryotic cells. FASEB J. 1995;9:1311–1318
  10. Almoguera C, Shibata D, Forrester K, et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell. 1988;53:549–554
  11. Smit VT, Boot AJ, Smits AM, et al. KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res. 1988;16:7773–7782
  12. Arber N, Shapira I, Ratan J, et al. Activation of c-K-ras mutations in human gastrointestinal tumors. Gastroenterology. 2000;118:1045–1050
  13. Bos JL, Fearon ER, Hamilton SR, et al. Prevalence of ras gene mutations in human colorectal cancers. Nature. 1987;327:293–297
  14. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525–532
  15. Sheng H, Shao J, Dubois RN. K-Ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase B1. Cancer Res. 2001;61:2670–2675
  16. Tuveson DA, Shaw AT, Willis NA, et al. Endogenous oncogenic K-ras (G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell. 2004;5:375–387
  17. Johnson L, Mercer K, Greenbaum D, et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature. 2001;410:1111–1116
  18. Guerra C, Mijimolle N, Dhawahir A, et al. Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell. 2003;4:111–120
  19. Janssen KP, el-Marjou F, Pinto D, et al. Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in mice. Gastroenterology. 2002;123:492–504
  20. McConnell BB, Ghaleb AM, Nandan MO, et al. The diverse functions of Krüppel-like factors 4 and 5 in epithelial biology and pathobiology. BioEssays. 2007;29:549–557
  21. Ghaleb AM, Nandan MO, Chanchevalap S, et al. Krüppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation. Cell Res. 2005;15:92–96
  22. Dang DT, Pevsner J, Yang VW. The biology of the mammalian Krüppel-like family of transcription factors. Int J Biochem Cell Biol. 2000;32:1103–1121
  23. Kaczynski J, Cook T, Urrutia R. Sp1- and Krüppel-like transcription factors. Genome Biol. 2003;4:206;1–206.8
  24. Conkright MD, Wani MA, Anderson KP, et al. A gene encoding an intestinal-enriched member of the Krüppel-like factor family expressed in intestinal epithelial cells. Nucleic Acids Res. 1999;27:1263–1270
  25. Sun R, Chen X, Yang VW. Intestinal-enriched Krüppel-like factor (Krüppel-like factor 5) is a positive regulator of cellular proliferation. J Biol Chem. 2001;276:6897–6900
  26. Chanchevalap S, Nandan MO, McConnell BB, et al. Krüppel-like factor 5 is an important mediator for lipopolysaccharide-induced proinflammatory response in intestinal epithelial cells. Nucleic Acids Res. 2006;34:1216–1223
  27. Chen C, Benjamin MS, Sun X, et al. KLF5 promotes cell proliferation and tumorigenesis through gene regulation and the TSU-Pr1 human bladder cancer cell line. Int J Cancer. 2006;118:1346–1355
  28. Ziemer LT, Pennica D, Levine AJ. Identification of a mouse homolog of the human BTEB2 transcription factor as a beta-catenin-independent Wnt-1-responsive gene. Mol Cell Biol. 2001;21:562–574
  29. Nandan MO, Chanchevalap S, Dalton WB, et al. Krüppel-like factor 5 promotes mitosis by activating the cyclin B1/Cdc2 complex during oncogenic Ras-mediated transformation. FEBS Lett. 2005;579:4757–4762
  30. Nandan MO, Yoon HS, Zhao W, et al. Krüppel-like factor 5 mediates the transforming activity of oncogenic H-Ras. Oncogene. 2004;23:3404–3413
  31. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949–954
  32. Johnson L, Greenbaum D, Cichowski K, et al. K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev. 1997;11:2468–2481
  33. Koera K, Nakamura K, Nakao K, et al. K-ras is essential for the development of the mouse embryo. Oncogene. 1997;15:1151–1159
  34. Chanchevalap S, Nandan MO, Merlin D, et al. All-trans retinoic acid inhibits proliferation of intestinal epithelial cells by inhibiting expression of the gene encoding Krüppel-like factor 5. FEBS Lett. 2004;578:99–105
  35. Tong D, Czerwenka K, Heinze G, et al. Expression of KLF5 is a prognostic factor for disease-free survival and overall survival in patients with breast cancer. Clin Cancer Res. 2006;12:2442–2448
  36. Lee JC, Wang ST, Lai MD, et al. K-ras gene mutation is a useful predictor of the survival of early stage colorectal cancers. Anticancer Res. 1996;16:3839–3844
  37. Samowitz WS, Curtin K, Schaffer D, et al. Relationship of Ki-ras mutations in colon cancers to tumor location, stage, and survival: a population-based study. Cancer Epidemiol Biomarkers Prev. 2000;9:1193–1197
  38. Nemunaitis J, Cox J, Hays S, et al. Prognostic role of K-ras in patients with progressive colon cancer who received treatment with Marimastat (BB2516). Cancer Invest. 2000;18:185–190
  39. Belly RT, Rosenblatt JD, Steinmann M, et al. Detection of mutated K12-ras in histologically negative lymph nodes as an indicator of poor prognosis in stage II colorectal cancer. Clin Colorectal Cancer. 2001;1:110–116
  40. Bateman NW, Tan D, Pestell RG, et al. Intestinal tumor progression is associated with altered function of KLF5. J Biol Chem. 2004;279:12093–12101
  41. Sansom OJ, Meniel V, Wilkins JA, et al. Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo. Proc Natl Acad Sci U S A. 2006;103:14122–14127
  42. Jackson EL, Willis N, Mercer K, et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 2001;15:3243–3248
  43. Perez-Mancera PA, Tuveson DA. Physiological analysis of oncogenic K-ras. Methods Enzymol. 2005;407:676–690

 Supported in part by National Institutes of Health grants DK52230, DK64399, DK76742, and CA84197.

 The authors report that no conflicts of interest exist.

PII: S0016-5085(07)01849-5

doi: 10.1053/j.gastro.2007.10.023

Gastroenterology
Volume 134, Issue 1 , Pages 120-130 , January 2008

Article Tools

* Image Usage & Resolution